Nov 12, 2019 / 10:00PM GMT
Operator
Good day, ladies and gentlemen. My name is Kat, and I'll be your conference operator today. At this time, I would like to welcome everyone to Analytics (sic) [Oncolytics] Biotech Third Quarter 2019 Results Conference Call. (Operator Instructions) I will now turn the call over to your host, Michael Moore, Vice President, Investor Relations and Corporate Communications. Sir, the floor is yours.
Michael Moore - Oncolytics Biotech Inc. - VP of IR & Corporate Communications
Thanks, Kat. Good afternoon, ladies and gentlemen, and thank you for joining us on our call today to discuss our third quarter and corporate update, including our updated catalyst milestones. With me on the call this afternoon from Oncolytics are Dr. Matt Coffey, President and Chief Executive Officer; Kirk Look, Chief Financial Officer; and Andrew de Guttadauro, Global Head of Business Development.
On today's call, Dr. Coffey will review our clinical and operational progress, including a recap of catalyst milestones. Andrew will touch on our business development progress and our
Q3 2019 Oncolytics Biotech Inc Earnings Call Transcript
Feb 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers